I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 50 200 VND 0.2% Market Closed
Market Cap: 7.7T VND

Intrinsic Value

The intrinsic value of one IMP stock under the Base Case scenario is 41 043.76 VND. Compared to the current market price of 50 200 VND, Imexpharm Corp is Overvalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IMP Intrinsic Value
41 043.76 VND
Overvaluation 18%
Intrinsic Value
Price
I
Worst Case
Base Case
Best Case

Valuation History
Imexpharm Corp

What is Valuation History?
Ask AI Assistant
What other research platforms think about IMP?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is IMP valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Imexpharm Corp.

Explain Valuation
Compare IMP to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IMP?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Imexpharm Corp

Current Assets 1.7T
Cash & Short-Term Investments 395.7B
Receivables 459B
Other Current Assets 805.4B
Non-Current Assets 1.3T
Long-Term Investments 67B
PP&E 765.6B
Intangibles 73.9B
Other Non-Current Assets 400.9B
Current Liabilities 591.4B
Accounts Payable 154.2B
Accrued Liabilities 105.6B
Short-Term Debt 202.9B
Other Current Liabilities 128.7B
Non-Current Liabilities 177B
Long-Term Debt 170B
Other Non-Current Liabilities 7B
Efficiency

Free Cash Flow Analysis
Imexpharm Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Imexpharm Corp

Revenue
2.5T VND
Cost of Revenue
-1.5T VND
Gross Profit
980.8B VND
Operating Expenses
-526.2B VND
Operating Income
454.6B VND
Other Expenses
-135B VND
Net Income
319.7B VND
Fundamental Scores

IMP Profitability Score
Profitability Due Diligence

Imexpharm Corp's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROIC
Healthy Gross Margin
Positive ROIC
Healthy Operating Margin
55/100
Profitability
Score

Imexpharm Corp's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

IMP Solvency Score
Solvency Due Diligence

Imexpharm Corp's solvency score is 89/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Low D/E
89/100
Solvency
Score

Imexpharm Corp's solvency score is 89/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IMP Price Targets Summary
Imexpharm Corp

Wall Street analysts forecast IMP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMP is 54 842 VND with a low forecast of 48 783 VND and a high forecast of 60 900 VND.

Lowest
Price Target
48 783 VND
3% Downside
Average
Price Target
54 842 VND
9% Upside
Highest
Price Target
60 900 VND
21% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for IMP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one IMP stock?

The intrinsic value of one IMP stock under the Base Case scenario is 41 043.76 VND.

Is IMP stock undervalued or overvalued?

Compared to the current market price of 50 200 VND, Imexpharm Corp is Overvalued by 18%.

Back to Top